ArticleDiscover oncology2025

TMCO1, as a potential biomarker of prognosis and immunotherapy response, regulates head and neck squamous cell carcinoma proliferation and migration.

Ting Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.